Tuesday, November 22, 2016

Genmab shares hit record high as U.S. widens use of cancer drug

COPENHAGEN, Nov 22 (Reuters) - Shares in Danish biotech

company Genmab jumped to a record high on Tuesday after

U.S. regulators approved widening the use its blood cancer drug

Darzalex, prompting the...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)